EHA-MSH Hematology Tutorial

EHA is joining forces with the Malaysian Society of Haematology (MSH) to organize the EHA-MSH Hematology Tutorial on Hodgkin Lymphoma.

Date: April 17-18, 2024
Format: In-Person
Location: Kuala Lumpur, Malaysia

Chairs: 
Prof Haris Abdul Rahman, Vice-president, Malaysian Society of Haematology (MSH)

Register here

Goal of the meeting

This EHA-led hematology tutorial on Hodgkin Lymphoma is an educational meeting that is part of the the pre-congress program, preceding MSH's Annual Scientific Congress. Hodgkin Lymphoma is an area in which in the outcomes in Malaysia still lag behind those seen in internationally published data. As such this meeting aims to improve the treatment, diagnosis and public awareness of the condition in Malaysia and surroundings, further encouraging early detection of the disease. 

Target audience

Hematologists, Internists, Specialized Nurses, Lab specialists/technicians and Hematopathologists with a particular interest in Hodgkin Lymphoma (Biology/Clinical), Immunohematology, Laboratory diagnosis and Imaging in hematology.

Program

The EHA-MSH Hematology tutorial program is designed to help attendees better understand the international standard in the diagnosis and treatment of Hodgkin Lymphoma. It further serves to learn whether adaption is needed in the current practice in the region, as well expose local clinicians and nurses to the latest developments in hematology in general. 

The program consists of updates by international speakers combined with patient-bases cases examples from the region. The knowledge gained by attendees is then tested by the international speakers as well.

Topics that will be covered are:

  • Basic Principles of Hodgkin Lymphoma
  • Histopathology and Diagnosis
  • Treatment of Newly Diagnosed Hodgkin Lymphoma
  • Managing first relapse and refractory disease with intention to cure
  • The roles of Novel Agents in the landscape of Hodgkin Lymphoma in 2024
  • Imaging in Hodgkin Lymphoma

The full program will be announced soon.

Learning objectives

After attending this tutorial, the participant will be able to

  • develop a deeper understanding on the treatment of Hodgkin Lymphoma, which is considered curable.
  • facilitate exposure of the current international standard for treatment of Hodgkin Lymphoma.
  • be exposed to the current diagnostic technique and imaging in assisting the existing treatment modalities to improve outcome, such as the latest diagnostic tools and use of PET imaging.
  • move away from conventional chemotherapy and incorporate the use of monoiclonal antibodies and targeted therapy in improving outcome.
  • identify the role of transplant as a treatment option in Hodgkin Lymphoma.
  • utilize the latest diagnostic techniques in Hodgkin Lymphoma to identify group with adverse outcome early in the diagnosis and employ a different treatment strategy.

Registration

Registration is now open. Click here for more information and to register.

  • Reduced registration fee for MSH members.
  • Early Bird rate until February 29, 2024.
  • It’s mandatory for Malaysian delegates who are interested in participating in the EHA-MSH Tutorial to register for the main congress.

Abstracts

Abstract submission is now closed.

  • Submission deadline: January 31, 2024
  • Acceptance and results: February 15, 2024
  • Presenter confirmation: February 29, 2024
  • Closing date for poster submission: March 31, 2024

Venue

Shangri-La Kuala Lumpur
11, Sultan Ismail Street, Kuala Lumpur,
50250 Kuala Lumpur, Wilayah Persekutuan
Kuala Lumpur

EBAH CME Accreditation

EBAH accredited stamp DEF2

EHA Hematology Tutorials are accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. EHA-MSH Hematology Tutorial on Hodgkin Lymphoma has been accredited by EBAH with 9 CME credits. Staying abreast of these scientific developments and keeping in touch with up-to-date views on clinical policy will enable you to raise your professional level, resulting in the best treatment for your patients.